Furthermore, these results suggest that the reduced capacity of serum in combination with the lower expression of ABCG1 on monocytes may result in an even more pronounced reduction in cholesterol efflux from MS monocytes in vivo. Here, ABCG1 is linked to myeloid sarcoma.